Serial Number 79000383
Registration 2946269
706

Registration Progress

Application Filed
Nov 7, 2003
Under Examination
Approved for Publication
Jan 19, 2005
Published for Opposition
Feb 8, 2005
Registered
May 3, 2005

Basic Information

Serial Number
79000383
Registration Number
2946269
Filing Date
November 7, 2003
Registration Date
May 3, 2005
Published for Opposition
February 8, 2005
Drawing Code
2

Status Summary

Current Status
Active
Status Code
706
Status Date
Apr 6, 2015
Registration
Registered
Classes
005

Rights Holder

Novo Nordisk Health Care AG

16
Address
The Circle 32/38
CH-8058 Zürich
CH

Ownership History

Novo Nordisk Health Care AG

Original Applicant
16
CH

Novo Nordisk Health Care AG

Owner at Publication
16
CH

Novo Nordisk Health Care AG

Original Registrant
16
CH

Legal Representation

Attorney
Claudia A. Smith

USPTO Deadlines

Next Renewal Deadline
3586 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2005-05-03)
Due Date
May 03, 2035
Grace Period Ends
November 03, 2035

Application History

32 events
Date Code Type Description
May 3, 2024 REM4 E COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 23, 2023 RNWL P INTERNATIONAL REGISTRATION RENEWED
Dec 4, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Aug 6, 2021 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 6, 2015 71AG O REGISTERED-SEC.71 ACCEPTED
Apr 6, 2015 NA71 E NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 3, 2015 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 27, 2015 ES71 I TEAS SECTION 71 RECEIVED
Jan 29, 2015 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 4, 2013 RNWL P INTERNATIONAL REGISTRATION RENEWED
May 7, 2011 15AK O REGISTERED - SEC. 15 ACKNOWLEDGED
May 7, 2011 71AG O REGISTERED-SEC.71 ACCEPTED
Apr 28, 2011 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 27, 2011 E15R I TEAS SECTION 15 RECEIVED
Apr 26, 2011 ES71 I TEAS SECTION 71 RECEIVED
Apr 4, 2011 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 4, 2011 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 31, 2007 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 1, 2006 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Mar 31, 2006 FISN P FINAL DECISION PROCESSED AND SENT TO IB
May 3, 2005 R.PR A REGISTERED-PRINCIPAL REGISTER
Feb 8, 2005 PUBO A PUBLISHED FOR OPPOSITION
Jan 19, 2005 NPUB O NOTICE OF PUBLICATION
Dec 3, 2004 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 29, 2004 ALIE A ASSIGNED TO LIE
Nov 22, 2004 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2004 RFNT P REFUSAL PROCESSED BY IB
May 27, 2004 CNRT F NON-FINAL ACTION MAILED
May 17, 2004 DOCK D ASSIGNED TO EXAMINER
Feb 9, 2004 NWAP I NEW APPLICATION ENTERED
Feb 5, 2004 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Detailed Classifications

Class 005
Human hemostatic preparations for injection for use in the treatment of hemophilia

Additional Information

Design Mark
The mark consists of a large design resembling a seven with a small oval nestling in its inner curve.
Color Claim
The colors blue, red and white are claimed as a feature of the mark.
Other
The color red appears in the outer portion of the oval nestling in the inner curve of a stylized design resembling the number seven, the inner portion of the oval is white; the blue color appears in the outer portion of the larger design resembling a seven, the inner portion is white.

Classification

International Classes
005